Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05200559
Title T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Haider Mahdi
Indications

ovarian cancer

skin melanoma

Advanced Solid Tumor

renal cell carcinoma

endometrial cancer

lung non-small cell carcinoma

Therapies

E7777 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST